Pharmaceutical formulations of bisphosphonates

Details for Australian Patent Application No. 2004308644 (hide)

Owner Novartis AG

Inventors Bateman, Simon David; Royce, Alan Edward; Serajuddin, Abu T. M.; Pudipeddi, Madhusudhan; Zannou, Erika Aina

Agent Davies Collison Cave

Pub. Number AU-B-2004308644

PCT Pub. Number WO2005/063218

Priority 60/532,334 23.12.03 US

Filing date 22 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 30 October 2008

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/00 (2006.01)

A61K 31/663 (2006.01)

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063218 Priority application(s): WO2005/063218

30 October 2008 Application Accepted

  Published as AU-B-2004308644

26 February 2009 Standard Patent Sealed

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308648-Use of rotigotine for the treatment or prevention of dopaminergic neurone loss

2004308643-Liposomes and liposomal compositions for vaccination and drug delivery